GLG
Get Started
GLG

Why the FDA Was Correct in Approving Biogen’s Aducanumab

The Food and Drug Administration on June 7 approved the first drug in 18 years intended to treat Alzheimer’s disease, aducanumab, despite its advisory committee and Alzheimer’s experts citing a lack of evidence that the drug works. In response, three scientists who served on the advisory committee resigned. To get a handle on the approval […]

Insights from GLG Institute’s 2021 Healthcare Leadership Summit

GLG’s 2021 Healthcare Leadership Summit came during a difficult pandemic year. From developing a vaccine in record time to accelerating technologies and maintaining a sense of community while operating remotely, we have faced unprecedented challenges and breakthroughs as an industry and a society. As we build back and borders reopen, we can create a more […]

Jeb Bush and Martin O’Malley on Reopening After COVID-19

The first vaccines in the United States were given in December 2020, followed by the rollout of what is probably the largest immunization campaign in history. Since that time, approximately 150,424,675 or 45% of Americans have been immunized. In May, President Biden set the goal of delivering at least one shot to 70% of adult […]

COVID Vaccinations in Hong Kong: An Update

On Thursday, 25 March, GLG, in partnership with the American Club, held an informal breakfast discussion with Professor Ivan Hung, co-convenor of the Expert Committee on Clinical Events Assessment Following Covid-19 Immunisation. During the breakfast, Professor Hung shared his candid perspective on the variety of vaccines supplied to Hong Kong. Topics included: Overview of the […]

COVID Vaccinations in Hong Kong: Q and A

On Thursday, 25 March, GLG, in partnership with the American Club, held an informal breakfast discussion with Professor Ivan Hung, co-convenor of the Expert Committee on Clinical Events Assessment Following Covid-19 Immunisation. During the breakfast, Professor Hung shared his candid perspective on the variety of vaccines supplied to Hong Kong. Topics included: Overview of the […]

Biden’s Healthcare Priorities

On March 9, 2021, GLG ran its quarterly Virtual Healthcare Leadership Convene. GLG clients heard from our Network Member experts about a range of topics that included the state of COVID-19 in Europe and the practical fundamentals of diversity, equity, and inclusion, and President Biden’s healthcare agenda. Highlights of the final session, The Outlook for […]

Updates on COVID-19: New Variants and Vaccination Campaigns

New variants of COVID-19 are emerging across the globe and accelerating the transmission of the virus. Meanwhile, governments have come under intense scrutiny for their handling of vaccine rollouts. In many states, vaccines have been purchased but not distributed. In others, governments have elected to roll out a first dose of the vaccine to a […]

An Overview of Southeast Asian Healthcare Delivery

As we emerge from COVID-19, there are likely to be major changes in the way primary medical care and other aspects of healthcare delivery are provided in Southeast Asia. To understand where we are going, it is best to have a good understanding of the today’s conditions in Malaysia, Thailand, and the Philippines, where the […]

Obamacare Likely to Be Safe from Supreme Court, Kathleen Sebelius Says

The Supreme Court is set to decide on the vote of the Affordable Care Act, also known as Obamacare, most likely in June as its last decision of the session. The Biden administration recently sent an “unusual” letter to the court urging it to uphold the law. To get more insights on the groundbreaking law […]

Kathleen Sebelius: ‘Trickle-Down Chaos’ Led to Poor COVID Response

To get past the COVID-19 pandemic, the U.S. needs strong federal leadership, which President Joe Biden will deliver, Kathleen Sebelius, who served as Secretary of Health and Human Services under President Barack Obama from 2009 to 2014, told GLG. Sebelius is one of America’s foremost experts on national and global health issues, human services, and […]

The Outlook for the Indian Pharmaceutical Industry

Heightened by the coronavirus pandemic, public focus on the pharmaceutical industry never has been greater. One important part of the global pharmaceutical ecosystem are India’s contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs). To find out about the current state of those companies and where they are headed, GLG recently met with […]

The Future of Digital Health in India

The digital health market has been booming in India since COVID-19, but the industry may face a reckoning once most of the nation has been vaccinated. Will doctors still schedule telehealth visits when it’s safe to meet in person? If not, how will digital health companies evolve to create an end-to-end experience that works for both […]

Speaker Biographies

Hilary Malone PhD, has over 25 years of experience in global drug development, regulatory &government affairs, manufacturing and commercialization within the biopharma industry. Hilary hassignificant board level and executive committee experience including large scale organizationalrestructuring/transformation/integration, major M&A, biotech start-up, capital raising, investorrelations and pre-IPO.​

Hilary is currently CEO of Stylus Medicine, a private genetic medicine biotech company. Previously sheserved as CEO of a Series-A neuroscience company. Prior to these roles, Hilary served as COO & EVP atValo Health Inc., Chief Regulatory Officer & SVP at Sanofi Inc., and Chief Regulatory Officer & SVP atPfizer and Wyeth. Previous experience also includes senior regulatory and drug development roles atReata Pharmaceuticals Inc., AstraZeneca plc and GlaxoSmithKline plc.​

Hilary also serves on the Board of Directors of Hansa Biopharma and Adthera Bio. Hilary holds a PhD inMolecular Neuropharmacology and a BSc in Physiology.

Dr. Thomas Lönngren is Director at his own company PharmaExec Consulting AB. He is the Chairman of the Board of directors at Egetis Therapeutics AB, Sweden. Dr Lönngren also serves as board member at Compass Pathways PLC, London UK and NDA Group, Sweden. He acts as advisor to the following companies and organizations: NDA group, Sweden, Sweden, Artis Venture, San Francisco, US, Fujimoto Japan, Skin2Neuron Pty Ltd, Sydney, Australia, US, Special advisor to the Centre for Innovation in Regulatory Science (CIRS), London UK. From 2001 until2011, Mr.Lönngren served as the Executive Director of the European Medical Agency. He was previously Deputy General Director of the Swedish Medical Product Agency until 2000. He has a degree in pharmacy and MSc in Social and Regulatory Pharmacy from Uppsala University. He is also an Honorary Member of the Royal Pharmaceutical Society of Great Britain, Honorary Fellow of the Royal College of Physicians in Great Britain, Honorary Doctorate from the University of Uppsala, Honorary Doctorate from University of Bath, UK.

Speaker Biographies

Marie-Anne Aymerich

Marie-Anne has built a portfolio of senior advisory and non-executive roles, following a successful international career in the FMCG and Luxury sectors. She is a non-executive director of Haleon, a FTSE100 company listed in 2022 after the demerger from GSK. She is also chairwoman of Haleon Environment and Societal Sustainability committee. She is the executive director of the Pierre Fabre Group where she also sits on the Strategic Committee, and she is a Board Member of The Academy of St. Martin-in-the-Fields, one of the world’s most prestigious chamber orchestras. She is also an angel investor and focuses her time and investments on start-ups with the strongest purpose and impact.

Marie-Anne is also a regular lecturer at HEC Paris on purposeful leadership, and she has created a serious game called “Planet Purpose” to upskill people on sustainability and purpose. Throughout her 35year executive career she delivered a strong track-record of business performance and growth in brands and portfolio in both developed and emerging economies.

As a senior leader with Unilever, she led a number of different personal care categories across France, Spain and the USA – including managing the Dove brand worldwide and culminating in leading Unilever’s global Oral Care division. She also worked for LVMH as Brand General Manager of Dior Perfumes and Cosmetics worldwide. Marie-Anne was also Vice-President of Imagine for Margo – Children with Cancer for ten years, a charity she helped found in 2011 with the goal of eradicating children’s cancer. The charity is the #1 charity focused on child cancer in France and has fundraised more than €14m since its creation. Marie-Anne is a graduate from HEC Paris. She is married and has two children aged 29 and 26.

Patrick Jephson

Patrick Jephson is a consultant, journalist, broadcaster and New York Times bestselling author, based in Washington D.C. He is a published authority on corporate and personal branding and crisis communications, addressing conferences worldwide as well as events at the U.S. State Department, the American University and the Annenberg School for Communication and Journalism.

With more than twenty-five years’ experience in the government, luxury and family office sectors, Patrick’s portfolio has included globally admired brands as well as national agencies and NGOs. He has also worked on reputation and legacy briefs with European, Middle Eastern and Asian families, including royalty. He now writes, presents, and advises on factual and drama TV programs, appearing on every major American and many international networks. He was recently an expert consultant to the award-winning Netflix series The Crown and provided live commentary on the Coronation of King Charles.

Patrick owes much of his practical communications and protocol experience to Princess Diana, who chose him to be her equerry and only private secretary/chief of staff. He served the Princess for eight years, responsible for all aspects of her public life, global humanitarian initiatives, and private organization. Having worked for an internationally high-profile woman (and as the father of two professionally successful daughters) he feels a special affinity for cross-cultural, gender and perception issues.

Patrick was born and raised in Ireland and holds a master’s degree in political science from Cambridge University. As an officer in the British Royal Navy, he served all over the world before being selected for royal duty. He is a citizen of the U.K., U.S.A., Ireland, and Canada.